n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with ryanodine in 1 studies
| Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (ryanodine) | Trials (ryanodine) | Recent Studies (post-2010) (ryanodine) |
|---|---|---|---|---|---|
| 214 | 5 | 58 | 2,894 | 3 | 237 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghelardoni, S; Ronca, F; Ronca-Testoni, S; Yu, G; Zucchi, R | 1 |
1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and ryanodine
| Article | Year |
|---|---|
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca(2+) release in rat heart.
Topics: Adenosine; Animals; Calcium; Dantrolene; Hemodynamics; Male; Muscle Relaxants, Central; Myocardial Reperfusion Injury; Myocardium; Organ Culture Techniques; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Ryanodine; Sarcoplasmic Reticulum; Vasodilator Agents | 2001 |